Mexico Infectious Disease Molecular Diagnostics Market Size & Outlook
Related Markets
Mexico infectious disease molecular diagnostics market highlights
- The Mexico infectious disease molecular diagnostics market generated a revenue of USD 173.4 million in 2020 and is expected to reach USD 214.6 million by 2028.
- The Mexico market is expected to grow at a CAGR of 2.7% from 2021 to 2028.
- In terms of segment, reagents was the largest revenue generating product in 2020.
- Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious disease molecular diagnostics market data book summary
| Market revenue in 2020 | USD 173.4 million |
| Market revenue in 2028 | USD 214.6 million |
| Growth rate | 2.7% (CAGR from 2020 to 2028) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.5% of the global infectious disease molecular diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Latin America, Brazil infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2028.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 214.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Mexico infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 67.07% in 2024. Horizon Databook has segmented the Mexico infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is a prominent market for infectious diseases molecular diagnostics in Latin America. Due to the large population, controlling the incidence of infectious diseases is a major challenge in Mexico. Healthcare institutions have undertaken initiatives to spread awareness about early diagnosis of infectious diseases through healthcare camps.
Favorable government regulations pertaining to approval of molecular diagnostics are expected to boost market growth. In Mexico, COFEPRIS—division of the Mexican Ministry of Health—governs the approval process for IVDs and molecular diagnostics.
The organization announced these plans in early 2017. For instance, in July 2020, COFEPRIS approved DiaCarta’s QuantiVirus SARS-CoV-2 test for marketing in Mexico, which is a PCRbased test. The test has been evaluated and approved by the Ministry of Health through the Institute of Diagnostic and Epidemiological Reference (InDRE), in compliance with the guidelines established by WHO.
Reasons to subscribe to Mexico infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico Infectious Disease Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
